1
|
Rolfes V, Bittner U, Gerhards H, Krüssel JS, Fehm T, Ranisch R, Fangerau H. Artificial Intelligence in Reproductive Medicine - An Ethical Perspective. Geburtshilfe Frauenheilkd 2023; 83:106-115. [PMID: 36643877 PMCID: PMC9833891 DOI: 10.1055/a-1866-2792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Accepted: 05/29/2022] [Indexed: 01/13/2023] Open
Abstract
Artificial intelligence is steadily being integrated into all areas of medicine. In reproductive medicine, artificial intelligence methods can be utilized to improve the selection and prediction of sperm cells, oocytes, and embryos and to generate better predictive models for in vitro fertilization. The use of artificial intelligence in this field is justified by the suffering of persons or couples who wish to have children but are unable to conceive. However, research into the use of artificial intelligence in reproductive medicine is still in the early experimental stage and furthermore raises complex normative questions. There are ethical research challenges because evidence of the efficacy of certain pertinent systems is often lacking and because of the increased difficulty of ensuring informed consent on the part of the affected persons. Other ethically relevant issues include the potential risks for offspring and the difficulty of providing sufficient information. The opportunity to fulfill the desire to have children affects the welfare of patients and their reproductive autonomy. Ultimately, ensuring more accurate predictions and allowing physicians to devote more time to their patients will have a positive effect. Nevertheless, clinicians must be able to process patient data conscientiously. When using artificial intelligence, numerous actors are involved in making the diagnosis and deciding on the appropriate therapy, raising questions about who is ultimately responsible when mistakes occur. Questions of fairness arise with regard to resource allocation and cost reimbursement. Thus, before implementing artificial intelligence in clinical practice, it is necessary to critically examine the quantity and quality of the data used and to address issues of transparency. In the medium and long term, it would be necessary to confront the undesirable impact and social dynamics that may accompany the use of artificial intelligence in reproductive medicine.
Collapse
Affiliation(s)
- Vasilija Rolfes
- 9170Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany,Korrespondenzadresse Vasilija Rolfes 9170Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät,
Heinrich-Heine-Universität DüsseldorfMoorenstraße 540225
DüsseldorfGermany
| | - Uta Bittner
- 9170Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany,84614Institut für Sozialforschung und Technikfolgenabschätzung, Ostbayerische Technische Hochschule Regensburg, Regensburg, Germany
| | - Helene Gerhards
- 84614Institut für Sozialforschung und Technikfolgenabschätzung, Ostbayerische Technische Hochschule Regensburg, Regensburg, Germany
| | - Jan-Steffen Krüssel
- Klinik für Frauenheilkunde und Geburtshilfe, Universitäres interdisziplinäres Kinderwunschzentrum Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf,
Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | - Tanja Fehm
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
| | - Robert Ranisch
- Juniorprofessur für Medizinische Ethik mit Schwerpunkt auf Digitalisierung, Universität Potsdam, Fakultät für Gesundheitswissenschaften Brandenburg, Potsdam, Germany,Forschungsstelle „Ethik der Genom-Editierung“, Institut für Ethik und Geschichte der Medizin, Eberhard-Karls-Universität Tübingen Medizinische Fakultät, Tübingen,
Germany
| | - Heiner Fangerau
- 9170Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
| |
Collapse
|
2
|
Krug H, Gerhards H, Bittner U, Scorna U, Kaufner N, Kokott LE, Rolfes V, Fangerau H, Weber K. [Capable or incapable of giving consent? Assessing a patient's capacity to consent: Procedures and challenges in daily clinical practice]. Z Evid Fortbild Qual Gesundhwes 2022; 172:23-30. [PMID: 35760745 DOI: 10.1016/j.zefq.2022.04.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Revised: 03/24/2022] [Accepted: 04/24/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND/OBJECTIVES The capacity of patients to give consent (CTC) is an indispensable prerequisite for informed consent to medical measures. When there is doubt about a patient's CTC, careful assessment is therefore required. Despite a broad theoretical discussion about the conception of CTC and possible procedures for its assessment, there is often a lack of orientation towards binding standardized procedural guidelines in everyday clinical practice. As a consequence, the results of CTC assessments are inconsistent, revealing both interdisciplinary and interindividual variability. In order to improve the quality of CTC assessment, more detailed knowledge about the procedures as well as the problems of CTC testing is needed. Therefore, the aim of this explorative telephone survey was to get an impression of the actual procedures that clinicians apply when in doubt about a patient's CTC. In particular, participants in the survey were asked about the weighting of individual CTC criteria and the difficulties with their application. METHODS Based on structured questionnaires, telephone interviews with 26 physicians working in German hospitals in the fields of neurology, anaesthesiology, surgery, internal medicine, gynaecology, and reconstructive/aesthetic surgery were conducted. The answers were documented using the paper-and-pencil method, and answers to open questions were summarized with the help of a qualitative data analysis software and a thematic coding scheme. RESULTS The majority of respondents reported that "sometimes to very often" they had doubts about their patients' CTC, with the examination being mostly conducted in an individual approach without formalized, standardized specifications. Regarding the question about the weighting of the seven assessment criteria proposed in the questionnaire, their importance was predominantly evaluated as being in the range of "partially important" to "very important". Difficulties in the clinical assessment were indicated in relation to the patients themselves, the relationship between physicians and patients, and the assessment situation. The perception of difficulties in the examination of CTC is apparently independent of the relevance attributed to the specific criterion for CTC. DISCUSSION AND CONCLUSION Overall, the results show a high level of agreement with the relevance of the seven CTC criteria included in the survey, but at the same time revealed various verification difficulties. Some of the respondents would like to have more support in determining their patients' CTC. The survey results suggest that precise training and adequate time resources are paramount to this sensitive medical context.
Collapse
Affiliation(s)
- Henriette Krug
- Medical School Hamburg, University of Applied Sciences and Medical University, Fakultät Gesundheitswesen, Hamburg, Deutschland.
| | - Helene Gerhards
- Institut für Sozialforschung und Technikfolgenabschätzung, Regensburg Center of Health Sciences and Technology, Ostbayerische Technische Hochschule Regensburg, Regensburg, Deutschland
| | - Uta Bittner
- Institut für Sozialforschung und Technikfolgenabschätzung, Regensburg Center of Health Sciences and Technology, Ostbayerische Technische Hochschule Regensburg, Regensburg, Deutschland; Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland
| | - Ulrike Scorna
- Institut für Sozialforschung und Technikfolgenabschätzung, Regensburg Center of Health Sciences and Technology, Ostbayerische Technische Hochschule Regensburg, Regensburg, Deutschland
| | - Nicla Kaufner
- Institut für Sozialforschung und Technikfolgenabschätzung, Regensburg Center of Health Sciences and Technology, Ostbayerische Technische Hochschule Regensburg, Regensburg, Deutschland
| | - Linda Ellen Kokott
- Institut für Sozialforschung und Technikfolgenabschätzung, Regensburg Center of Health Sciences and Technology, Ostbayerische Technische Hochschule Regensburg, Regensburg, Deutschland
| | - Vasilija Rolfes
- Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland
| | - Heiner Fangerau
- Institut für Geschichte, Theorie und Ethik der Medizin, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland
| | - Karsten Weber
- Institut für Sozialforschung und Technikfolgenabschätzung, Regensburg Center of Health Sciences and Technology, Ostbayerische Technische Hochschule Regensburg, Regensburg, Deutschland
| |
Collapse
|
3
|
Rolfes V, Bittner U, Kruessel JS, Fehm T, Fangerau H. In vitro gametogenesis: A benefit for women at advanced and very advanced age? An ethical perspective. Eur J Obstet Gynecol Reprod Biol 2022; 272:247-250. [PMID: 35405453 DOI: 10.1016/j.ejogrb.2022.03.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 07/08/2021] [Accepted: 03/25/2022] [Indexed: 11/18/2022]
Abstract
Assisted reproductive technologies (ART) may be supplemented with in vitro gametogenesis (IVG). Although IVG is still experimental the question arises whether IVG offers any moral advantages compared to implemented methods. The aim of the paper is to present the landscape of ethical arguments in favour or against IVG. ART-related ethical issues in relation to reproductive autonomy, health risks for the woman and foetus, the welfare of the future child, the adverse effects of advanced motherhood, gender equality, and justice are similar for IVG, oocyte cryopreservation, and oocyte donation. IVG may have the following advantages: (I) the psychological and physical burden of stimulation and puncture of the oocyte could be avoided; (II) women do not necessarily have to cope with motherhood at young age; (III) ethical doubts associated with oocyte donation would be eliminated; (IV) by using IVG in combination with preimplantation diagnostics, it is more likely to find suitable oocytes or embryos to increase the probability of pregnancy; (V) women would have the opportunity to decide how many oocytes should be generated and how often an attempt should be made to achieve pregnancy. Simultaneously, however, the advent of IVG may lead to new moral disadvantages: pressure on women to give birth at an advanced age or pressure on women to follow 'male' career structures. Additionally, the reimbursement of costs related to IVG is an open question, especially if equal opportunities regarding motherhood are linked to demands for equal access to ART. An early discussion about the ethical, legal, and social consequences for IVG is necessary.
Collapse
Affiliation(s)
- Vasilija Rolfes
- Department of the History, Philosophy and Ethics of Medicine, Medical Faculty, University Hospital Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany.
| | - Uta Bittner
- Department of the History, Philosophy and Ethics of Medicine, Medical Faculty, University Hospital Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany.
| | - Jan-Steffen Kruessel
- Department of Obstetrics and Gynaecology, Medical Faculty, University Hospital Dusseldorf, Dusseldorf, Germany.
| | - Tanja Fehm
- Department of Obstetrics and Gynaecology, Medical Faculty, University Hospital Dusseldorf, Dusseldorf, Germany.
| | - Heiner Fangerau
- Department of the History, Philosophy and Ethics of Medicine, Medical Faculty, University Hospital Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany.
| |
Collapse
|
4
|
Gerhards H, Weber K, Bittner U, Fangerau H. Machine Learning Healthcare Applications (ML-HCAs) Are No Stand-Alone Systems but Part of an Ecosystem - A Broader Ethical and Health Technology Assessment Approach is Needed. Am J Bioeth 2020; 20:46-48. [PMID: 33103972 DOI: 10.1080/15265161.2020.1820104] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
|
5
|
Weber K, Frommeld D, Gerhards H, Krug H, Kokott LE, Bittner U. Speaking About Enhancement-Methodological Issues and Historical Examples. AJOB Neurosci 2020; 11:254-256. [PMID: 33196361 DOI: 10.1080/21507740.2020.1831650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
| | | | | | | | | | - Uta Bittner
- OTH Regensburg
- Heinrich Heine University Düsseldorf
| |
Collapse
|
6
|
Rolfes V, Bittner U, Fangerau H, Weber K. Is It All About Revising, Correcting, and Transferring Genes? Am J Bioeth 2020; 20:30-32. [PMID: 32804061 DOI: 10.1080/15265161.2020.1782526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
|
7
|
Becker R, Keller T, Kiesewetter H, Fangerau H, Bittner U. Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. Arch Gynecol Obstet 2013; 288:41-8. [PMID: 23389246 PMCID: PMC3682099 DOI: 10.1007/s00404-013-2723-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2012] [Accepted: 01/15/2013] [Indexed: 12/17/2022]
Abstract
OBJECTIVE To identify patients at very high risk for adverse pregnancy outcome (APO) at the 20- to 23-week scan and to assess the effectiveness of Aspirin (ASS) and low molecular weight heparin (LMWH) starting after this examination. PATIENTS AND METHODS By applying an algorithm based on multivariate logistic regression analysis using the parameters maternal age, parity, body mass index (BMI), mean pulsatility index of both uterine arteries (meanPI), presence of uni- or bilateral notch, and depth of notch (mean notch index (meanNI), we retrospectively calculated the individual risk for APO of 21,302 singleton pregnancies. We isolated a subgroup of 426 patients with the highest calculated probability for APO (cpAPO > 27.8 %). 147 had been treated with ASS; 73 with LMWH, 15 patients with a combination of ASS and LMWH, and 191 patients had not received anticoagulants. RESULTS Administration of ASS starting after 20 gestational weeks in comparison to non-treated patients significantly reduced the frequency of intrauterine/neonatal death (IUD/NND), preeclampsia <33 weeks (PE < 33), and preterm delivery <33 weeks (PD < 33), while the frequency of IUGR showed a tendency to be elevated (P = 0.061). The subgroup of high-risk patients treated with LMWH was characterised by a higher a priori risk for APO and showed no significant reduction of any form of APO but an increased frequency of PE. CONCLUSION Individual assessment of risk for APO by applying a simple algorithm based on biometrical/biographical as well as sonographic parameters may serve as basis for drug intervention studies. The administration of ASS in high-risk patients starting after 20 gestational weeks reduced the frequency of most of the severe forms of adverse pregnancy outcome in high-risk patients. A complication-reducing effect of LMWH starting after 20 weeks of gestation in patients could not be proven. From an ethical point of view, it may not be justified any more to preclude high-risk patients from administration of ASS or to perform studies of ASS against placebo.
Collapse
Affiliation(s)
- Rolf Becker
- Center for Prenatal Diagnosis and Human Genetics, Free University of Berlin, Kurfuerstendamm 199, 10719 Berlin, Germany.
| | | | | | | | | |
Collapse
|
8
|
Porzsolt F, Bittner U, Clouth J. Scientists and clinicians have to be on the qui VIVE: benefit, outcome, value and utility in health care as a challenge. J Public Health (Oxf) 2012. [DOI: 10.1007/s10389-012-0494-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
9
|
Becker R, Schmitz L, Kilavuz S, Stumm M, Wegner RD, Bittner U. ‘Normal’ nuchal translucency: a justification to refrain from detailed scan? Analysis of 6858 cases with special reference to ethical aspects. Prenat Diagn 2012; 32:550-6. [DOI: 10.1002/pd.3854] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Rolf Becker
- Center for prenatal diagnostics and human genetics; Charité; Berlin; Germany
| | - Lothar Schmitz
- Otto-Heubner Center for Pediatrics; Charité; Berlin; Germany
| | - Stefania Kilavuz
- Center for prenatal diagnostics and human genetics; Charité; Berlin; Germany
| | - Markus Stumm
- Center for prenatal diagnostics and human genetics; Charité; Berlin; Germany
| | - Rolf-Dieter Wegner
- Center for prenatal diagnostics and human genetics; Charité; Berlin; Germany
| | - Uta Bittner
- Institute of the History, Theory and Ethics of Medicine; University of Ulm; Ulm; Germany
| |
Collapse
|
10
|
Weber K, Bittner U, Manzeschke A, Rother E, Quack F, Dengler K, Fangerau H. Taking patient privacy and autonomy more seriously: why an Orwellian account is not sufficient. Am J Bioeth 2012; 12:51-53. [PMID: 22881858 DOI: 10.1080/15265161.2012.699147] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Affiliation(s)
- Karsten Weber
- Brandenburg University of Technology Cottbus, Germany.
| | | | | | | | | | | | | |
Collapse
|
11
|
Bittner U. Ethische Aspekte der Fertilitätsreservenschaffung bei gesunden Frauen. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1280052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
12
|
Bittner U, Eichinger T. An ethical assessment of postmenopausal motherhood against the backdrop of successful antiaging medicine. Rejuvenation Res 2011; 13:741-7. [PMID: 21208061 DOI: 10.1089/rej.2009.1012] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
By creating fertility reserves, women are now able to become pregnant using their own eggs, even after menopause. Multiple arguments already exist against postmenopausal motherhood, most of which stress the potential risk of damage involved due to the mother's advanced age. Consequently, the question arises: Can successful antiaging medicine be applied to preserve or enhance cognitive and physical capacity at an advanced age and invalidate these objections? In this article, we shall explore this issue further and come to three main conclusions: (1) Until now, enabling postmenopausal women to become pregnant has not been a specific objective of antiaging medicine. (2) Postmenopausal motherhood can find legitimacy through the development and success of antiaging medicine. (3) The acceptance of postmenopausal motherhoods in our society first requires that antiaging medicine itself find some sort of ethical legitimacy. To evaluate the arguments for and against antiaging medicine and postmenopausal motherhood, it is important to take into consideration two points more in depth, which are constantly being impacted by both medical arguments alike: (1) The identity and role of medicine itself as well as (2) the normative role of our body`s natural boundaries.
Collapse
Affiliation(s)
- Uta Bittner
- Department of Medical Ethics and History of Medicine, University of Freiburg, Freiburg, Germany.
| | | |
Collapse
|
13
|
Krug H, Müller O, Bittner U. [Technological intervention in the self? An ethical evaluation of deep brain stimulation relating to patient narratives]. Fortschr Neurol Psychiatr 2010; 78:644-51. [PMID: 21069629 DOI: 10.1055/s-0029-1245753] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Technological interventions into the brain raise a number of ethical questions, particularly, questions of personality change and control or manipulation of the human mind. Taking patients undergoing deep brain stimulation as an example, the authors analyse the possible impact of neurotechnologies on human self-perception in individual cases as well as in general. Following the concept of narrative-based medicine and ethics patients' narrations are presented in order to discuss the value of this approach for developing normative considerations as well as for deriving practical consequences regarding the physician-patient-relationship.
Collapse
Affiliation(s)
- H Krug
- Klinik und Poliklinik für Neurologie, Charité Universitätsmedizin Berlin.
| | | | | |
Collapse
|
14
|
|
15
|
|
16
|
Eicker B, Barth K, Bittner U, Marhoff P. Optimierung von Faltungskernen zur Bestimmung kleiner Gefäßdurchmesser in der digitalen Subtraktionsangiographie. BIOMED ENG-BIOMED TE 2009. [DOI: 10.1515/bmte.1988.33.s2.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
17
|
Barth K, Eicker B, Bittner U, Marhoff P. Computerauswertung der Funktion der linken Herzkammer mit digitaler Subtraktionsangiographie. BIOMED ENG-BIOMED TE 2009. [DOI: 10.1515/bmte.1988.33.s2.247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Düber C, Bittner U, Klose KJ, Haberern G, Thelen M. [Digital multilayer tomography. A description of the method and initial clinical results]. ROFO-FORTSCHR RONTG 1989; 151:477-82. [PMID: 2554388 DOI: 10.1055/s-2008-1047219] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
A set of projection images is acquired during longitudinal tomography with an image intensifier TV system. Reconstruction of tomograms in each desired plane is achieved by shifting and summing up of the digitalized projection images. Digital multilayer and conventional film tomograms mainly of the respiratory tract and skeleton have been compared in 100 patients. Image quality is comparable with both methods. Disadvantage of digital tomography is lower spatial resolution (512 x 512 matrix size); advantages include lower radiation dose, shorter study time, and facilities of digital imaging.
Collapse
Affiliation(s)
- C Düber
- Institut für Klinische Strahlenkunde, Johannes Gutenberg-Universität, Mainz
| | | | | | | | | |
Collapse
|